IMMUNOREACTANTS IN RHEUMATIC DISEASES

NIH RePORTER · NIH · R01 · $164,370 · view on reporter.nih.gov ↗

Abstract

Rheumatoid synovial effusions (and other inflammatory joint fluids are characterized by large numbers of T cells, many of which are activated, and another ill-defined population lacking cell surface receptors (E negative, Ig negative, Fc negative). Little is known about the functional significance of either population. There is evidence, however, for natural killer cell activity mediated by an Fc receptor negative NK cell. These characteristics are reminiscent of the results of the in vitro autologous mixed leukocyte reaction. We propose to analyze the following hypothesis; namely, in the rheumatoid joint B lymphocytes, transformed by an undefined stimulus, generate an autologous MLR. This leads to activation of T cells and the elaboration of factors that augment nonspecific cytotoxic activity. An additional consequence of this reaction would be the generation of large amounts of nonspecific T cell-derived helper activity. This thesis would predict that in the rheumatoid joint one would find evidence of an increased or secondary type of autologous MLR, an unusual population of AMLR stimulator cells, the presence of nonspecific cytotoxic cells lacking Fc receptors, and perhaps specific cytotoxic cells recognizing lymphocyte membrane defined antigen induced by the B cell transforming agent.

Key facts

NIH application ID
3154823
Project number
5R01AR014916-19
Recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO
SAM.gov UEI
UYTTZT6G9DT1
Principal Investigator
GARY S FIRESTEIN
Activity code
R01
Funding institute
NIH
Fiscal year
1989
Award amount
$164,370
Award type
5
Project period
1976-05-01 → 1990-12-31